195 related articles for article (PubMed ID: 19372222)
1. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.
Raaijmakers HC; Versteegh JE; Uitdehaag JC
J Biol Chem; 2009 Jul; 284(29):19572-9. PubMed ID: 19372222
[TBL] [Abstract][Full Text] [Related]
2. X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.
Lusher SJ; Raaijmakers HC; Vu-Pham D; Kazemier B; Bosch R; McGuire R; Azevedo R; Hamersma H; Dechering K; Oubrie A; van Duin M; de Vlieg J
J Biol Chem; 2012 Jun; 287(24):20333-43. PubMed ID: 22535964
[TBL] [Abstract][Full Text] [Related]
3. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
4. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
Wardell SE; Narayanan R; Weigel NL; Edwards DP
Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
[TBL] [Abstract][Full Text] [Related]
5. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.
Kauppi B; Jakob C; Färnegårdh M; Yang J; Ahola H; Alarcon M; Calles K; Engström O; Harlan J; Muchmore S; Ramqvist AK; Thorell S; Ohman L; Greer J; Gustafsson JA; Carlstedt-Duke J; Carlquist M
J Biol Chem; 2003 Jun; 278(25):22748-54. PubMed ID: 12686538
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
[TBL] [Abstract][Full Text] [Related]
7. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
Schoch GA; D'Arcy B; Stihle M; Burger D; Bär D; Benz J; Thoma R; Ruf A
J Mol Biol; 2010 Jan; 395(3):568-77. PubMed ID: 19913032
[TBL] [Abstract][Full Text] [Related]
8. 16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity.
Wagner BL; Pollio G; Leonhardt S; Wani MC; Lee DY; Imhof MO; Edwards DP; Cook CE; McDonnell DP
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8739-44. PubMed ID: 8710941
[TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
10. Differential interaction of RU486 with the progesterone and glucocorticoid receptors.
Zhang J; Tsai FT; Geller DS
J Mol Endocrinol; 2006 Aug; 37(1):163-73. PubMed ID: 16901932
[TBL] [Abstract][Full Text] [Related]
11. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
13. Atomic structure of progesterone complexed with its receptor.
Williams SP; Sigler PB
Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators.
Lusher SJ; Raaijmakers HC; Vu-Pham D; Dechering K; Lam TW; Brown AR; Hamilton NM; Nimz O; Bosch R; McGuire R; Oubrie A; de Vlieg J
J Biol Chem; 2011 Oct; 286(40):35079-86. PubMed ID: 21849509
[TBL] [Abstract][Full Text] [Related]
15. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
16. The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins.
Wagner BL; Pollio G; Giangrande P; Webster JC; Breslin M; Mais DE; Cook CE; Vedeckis WV; Cidlowski JA; McDonnell DP
Endocrinology; 1999 Mar; 140(3):1449-58. PubMed ID: 10067874
[TBL] [Abstract][Full Text] [Related]
17. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
18. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
Peeters BW; Ruigt GS; Craighead M; Kitchener P
Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
